Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Beta-catenin is a transcriptional activator and oncoprotein involved in the development of several cancers. Additionally we are shipping CBY1 Proteins (9) and CBY1 Kits (4) and many more products for this protein.
Showing 10 out of 34 products:
Human Polyclonal CBY1 Primary Antibody for EIA, FACS - ABIN951076
Yamano, Uzawa, Saito, Nakashima, Kasamatsu, Koike, Kouzu, Shinozuka, Nakatani, Negoro, Fujita, Tanzawa: Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma. in International journal of cancer. Journal international du cancer 2009
Show all 2 references for ABIN951076
Chibby functions in Xenopus ciliary assembly, embryonic development, and the regulation of gene expression.
FAM92 proteins interact with Cby1 to promote ciliogenesis via regulation of membrane-remodeling processes.
chronic Cby1 knockdown in colon cancer cells may counteract tumor progression by promoting the mesenchymal-to-epithelial transition process.
Cby's C-terminal domain alone binds to TC-1 (show SLC19A2 Antibodies) with significantly greater affinity compared to full-length Cby, implying that target binding of the coiled-coil domain is affected by the flanking disordered regions.
CBY1 downregulation in CML (show BCR Antibodies) comes from reduced protein stability when bound to 14-3-3sigma adapter protein (show TOLLIP Antibodies). Dissociation raises CBY1 protein levels by enhancing its stability. The ubiquitin proteasome system reduces 14-3-3sigma-bound CBY1 stability by SUMOylation.
Results show the hypermethylation of CBY1 and BCL2 (show BCL2 Antibodies)-like11 promoters proceeding from DNMT1 (show DNMT1 Antibodies) is a crucial component of their reduced expression, but it is not directly involved in chronic myeloid leukemia (show BCL11A Antibodies) resistance to imatinib.
Study showed that expression of Cby protein was strongly downregulated in laryngeal squamous cell carcinoma (LSCC) tumor tissues in comparison to normal laryngeal mucosa samples.
the impact of BCR (show BCR Antibodies)-ABL1 (show ABL1 Antibodies) on Chibby1, a beta (show SUCLA2 Antibodies) catenin (show CTNNB1 Antibodies) antagonist involved in cell differentiation and transformation
Stable expression of CBY1 drives beta catenin (show CTNNB1 Antibodies) cytoplasmatic translocation and impairs beta catenin (show CTNNB1 Antibodies) signaling in BCR-ABL (show ABL1 Antibodies) + cells.
Results from the association analysis suggest that common variation in CBY is not a cause for obesity in the Belgian population.
C-terminal polycystin-2 (show PKD2 Antibodies) influences the interaction with PIGEA14
Cby1 is required for efficient recruitment of Ahi1 (show AHI1 Antibodies), providing a possible molecular mechanism for the ciliogenesis defect in Cby1(-/-) cells.
Beta-catenin is a transcriptional activator and oncoprotein involved in the development of several cancers. The protein encoded by this gene interacts directly with the C-terminal region of beta-catenin, inhibiting oncogenic beta-catenin-mediated transcriptional activation by competing with transcription factors for binding to beta-catenin. Two transcript variants encoding different isoforms have been found for this gene.
chibby homolog 1
, leucine-rich protein
, ARPP-binding protein
, PKD2 interactor, Golgi and endoplasmic reticulum-associated 1
, PKD2 interactor, golgi and endoplasmic reticulum associated 1
, coiled-coil protein PIGEA-14
, cytosolic leucine-rich protein
, polycystin-2 interactor, Golgi- and endoplasmic reticulum-associated protein, 14 kDa
, protein chibby homolog 1